Inicio › Cáncer de seno › South Carolina

Ensayos clínicos de Cáncer de seno en South Carolina

23 estudios sobre Cáncer de seno buscan participantes en South Carolina.

Ciudades en South Carolina

Texto oficial del estudio (inglés)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Bon Secours St Francis Cancer Center, Greenville

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
y 12 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

CBD for Breast Cancer Primary Tumors

Medical University of South Carolina, Charleston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06148038

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

St. Joseph's Candler Bluffton Campus, Bluffton
SC Cancer Specialists - Hilton Head at St. Joseph's/Candler, Hilton Head Island
Levine Cancer Institute, Rock Hill

ReclutandoFase 3

Edades de 60 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06377852

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
St Francis Cancer Center ( Site 0093), Greenville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06966700

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Medical University of South Carolina, Charleston

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Hollings Cancer Center, Charleston

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT06492616

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Spartanburg Regional Healthcare System, Spartanburg

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Bon Secours - St. Francis Hospital, Greenville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
y 14 más

ReclutandoFase 3

Edades de 18 a 60 · Mujeres · Actualizado el 2 sept 2026 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

St Francis Cancer Center, Greenville

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06926868

E-Mindfulness Approaches for Living After Breast Cancer

Beaufort Memorial Hospital, Beaufort
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
y 10 más

ReclutandoFase 3

Edades de 18 a 50 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06748222

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Medical University of South Carolina, Charleston

ReclutandoFase 2

Edades de 18 a 55 · Mujeres · Actualizado el 27 jul 2026 · NCT06184750

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Prisma Health - Upstate (ITOR)_Edenfield ( Site 0053), Greenville

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT06686394

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Medical University of South Carolina, Charleston

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 abr 2026 · NCT04468061

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Medical University of South Carolina, Charleston
McLeod Regional Medical Center, Florence
y 5 más

ReclutandoFase 3

Edades de 50 a 70 · Todos los sexos · Actualizado el 23 abr 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

AnMed Health Cancer Center, Anderson
Beaufort Memorial Hospital, Beaufort
Saint Joseph's/Candler - Bluffton Campus, Bluffton
y 18 más

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Medical University of South Carolina, Charleston
McLeod Health, Florence

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Spartanburg Medical Center, Spartanburg

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT06401421

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Greenville

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Prisma Health Cancer Institute - Butternut, Greenville
Prisma Health Cancer Institute - Faris, Greenville
Prisma Health Cancer Institute - Eastside, Greenville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2025 · NCT03418961

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Roper St. Francis Physician Partners - Breast Surgery, Charleston
Tidelands Health Coastal Carolina Breast Center, Georgetown

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2025 · NCT03053193

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients

Prisma Health Cancer Institute, Greenville

ReclutandoEstudio observacional

Edades de 20 en adelante · Mujeres · Actualizado el 4 nov 2024 · NCT06672497

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.